financetom
Business
financetom
/
Business
/
CPS ENERGY CLOSES ON PREVIOUSLY ANNOUNCED ACQUISITION OF 1,632 MEGAWATT POWER GENERATION PORTFOLIO IN SOUTHEAST TEXAS
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CPS ENERGY CLOSES ON PREVIOUSLY ANNOUNCED ACQUISITION OF 1,632 MEGAWATT POWER GENERATION PORTFOLIO IN SOUTHEAST TEXAS
Sep 24, 2025 5:09 AM

SAN ANTONIO, Sept. 24, 2025 /PRNewswire/ -- Today, CPS Energy announced the closing on its acquisition of PROENERGY's four natural gas power generation facilities with an aggregate electric capacity of approximately 1,632 megawatts ("MW") for $1.387 billion, subject to customary net working capital adjustments. CPS Energy and PROENERGY previously announced the transaction on Sept. 16, 2025.

The assets acquired include state-of-the-art, recently constructed peaking natural gas plants in Harris, Brazoria, and Galveston counties in the Electric Reliability Council of Texas ("ERCOT") market. Under the terms of agreements between the parties, PROENERGY will continue to staff, operate, and maintain the acquired units, enabling safe and reliable operation and maintenance of the power plants.

The acquired assets are dual-fuel capable, providing CPS Energy future optionality to transition to a hydrogen fuel blend with favorable carbon emissions. By acquiring recently constructed, currently operating modern power plants that utilize proven technology already in use by CPS Energy, the company avoids higher construction costs, inflationary risk, and supply chain risks associated with building new facilities.

"The closing of this strategic acquisition marks yet another major step in strengthening the reliability and affordability of our generation portfolio," said Rudy D. Garza, President and CEO of CPS Energy. "This investment benefits our customers today while supporting our long-term energy plan and clean energy commitments."

J.P. Morgan acted as exclusive financial advisor and Dykema Gossett PLLC acted as legal advisor to CPS Energy with respect to the transaction. CIBC Capital Markets served as exclusive financial advisor and Latham & Watkins LLP served as legal advisor to PROENERGY.

About CPS Energy

Established in 1860, CPS Energy is the nation's largest public power, natural gas, and electric company, providing safe, reliable, and competitively-priced service to more than 950,000 electric and 389,000 natural gas customers in San Antonio and portions of seven adjoining counties. Our customers' combined energy bills rank among the lowest of the nation's 20 largest cities – while generating $9.6 billion in revenue for the City of San Antonio for 80 years. As a trusted and strong community partner, we continuously focus on job creation, economic development, and educational investment. We are powered by our skilled workforce, whose commitment to the community is demonstrated through our employees' volunteerism in giving back to our city and programs aimed at bringing value to our customers. CPS Energy is among the top public power wind energy buyers in the nation and number one in Texas for solar generation. 

About PROENERGY

PROENERGY is an engineering, R&D, and manufacturing powerhouse. The company addresses every need for fast-start power generation: turbine and package manufacturing, turnkey project execution, power purchase agreements, and asset lifecycle care for turbines and plants. Where others see impossible energy challenges, PROENERGY provides innovative aeroderivative solutions.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cps-energy-closes-on-previously-announced-acquisition-of-1-632-megawatt-power-generation-portfolio-in-southeast-texas-302565776.html

SOURCE CPS Energy

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
HEDGE FLOW-Hedge funds were pausing US AI bets as DeepSeek emerged, says Goldman
HEDGE FLOW-Hedge funds were pausing US AI bets as DeepSeek emerged, says Goldman
Jan 27, 2025
* Hedge funds reduce tech stock bets amid Chinese AI competition * Goldman Sachs ( GS ) notes hedge funds' reluctance to invest in U.S. tech sector * DeepSeek challenges U.S. AI dominance, raising investor concerns By Nell Mackenzie LONDON, Jan 27 (Reuters) - Hedge funds were already waiting to see if a U.S.-fostered, home-grown artificial intelligence boom would continue...
BMO on The Day, Week Ahead in Canada
BMO on The Day, Week Ahead in Canada
Jan 27, 2025
07:47 AM EST, 01/27/2025 (MT Newswires) -- Investors will get the advance reading on Canada's wholesale trade for December at 8:30 a.m. ET on Monday, noted Bank of Montreal (BMO). There's plenty to chew on later in the week, with the monthly real gross domestic product report for November out on Friday. The bank is looking for a 0.1% decline...
Discovery Silver to acquire Newmont's gold mining operations at Porcupine for $425M
Discovery Silver to acquire Newmont's gold mining operations at Porcupine for $425M
Jan 27, 2025
Jan 27 (Reuters) - Gold miner Discovery Silver ( DSVSF ) said on Monday it would acquire its peer Newmont's ( NEM ) stake in Porcupine Operations in Ontario, Canada, for $425 million. Newmont ( NEM ), after buying Australia-based Newcrest for $17.14 billion, announced in February 2024 it would divest non-core assets and trim its workforce to cut debt....
Akero Therapeutics Says Phase 2b Efruxifermin Study Shows 'Statistically Significant' Reversal of Cirrhosis
Akero Therapeutics Says Phase 2b Efruxifermin Study Shows 'Statistically Significant' Reversal of Cirrhosis
Jan 27, 2025
07:50 AM EST, 01/27/2025 (MT Newswires) -- Akero Therapeutics ( AKRO ) said Monday that a phase 2b study of its lead product candidate efruxifermin showed a statistically significant reversal of compensated cirrhosis caused by metabolic dysfunction-associated steatohepatitis, or MASH. The company said that among patients with baseline and week 96 biopsies, 39% of those treated with efruxifermin showed reversal...
Copyright 2023-2026 - www.financetom.com All Rights Reserved